| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
3 companies
Richman Eric I is a Director at Altimmune, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 9 buys and 6 sells.
Estimated insider holdings value: $3.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | GANX Gain Therapeutics, Inc. | Director | Buy | 17,000 | $1.22 | $20,670.00 | +3.1% | +58.9% | +40.2% | |
| May 25, 2022 | GANX Gain Therapeutics, Inc. | Chief Executive Officer | Buy | 2,482 | $2.58 | $6,403.56 | +1.2% | +28.7% | +74.0% | |
| May 20, 2022 | GANX Gain Therapeutics, Inc. | Chief Executive Officer | Buy | 13,256 | $2.79 | $37,034.48 | +3.2% | +38.4% | +80.1% | |
| Jun 8, 2018 | ADMA Adma Biologics, Inc. | Director | Buy | 5,230 | $4.78 | $24,999.40 | +16.7% | - | - | |
| Nov 9, 2017 | ADMA Adma Biologics, Inc. | Director | Buy | 25,000 | $2.15 | $53,750.00 | +396.8% | - | - | |
| Apr 13, 2016 | ALT Altimmune, Inc. | Director | Sale+OE | 329,354 | $2.20 | $724,578.80 | -31.8% | - | - | |
| Apr 8, 2016 | ALT Altimmune, Inc. | Director | Sale+OE | 11,767 | $2.20 | $25,887.40 | -3.2% | - | - | |
| Mar 13, 2015 | ADMA Adma Biologics, Inc. | Director | Buy | 3,500 | $7.88 | $27,570.00 | +140.0% | - | - |